Deva Holding
Pharmaceutical manufacturer Deva Holding A.S. is a Turkish Fortune 500 company with annual revenue of more than US$250 million and a staff of approximately 2,300 across its operations in Turkey, Germany, USA and New Zealand.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
EsomeprazoleEsomeprazole2017-03-062036
SuccinylcholineSuccinylcholine2020-12-21
—
TemozolomideTemozolomide2017-04-26
Amoxicillin clavulanate potassiumAmoxicillin, Clavulanate potassium2023-09-132026-2042
CeftriaxoneCeftriaxone2024-01-12
CyclosporineCyclosporine2024-05-212024-2039
ChlorpromazineChlorpromazine2024-09-24
FormoterolFormoterol2025-02-112023-2038
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use